A CP failed to identify and clarify a medication route discrepancy during the monthly MRR for a resident with a g-tube, NPO status, and moderate cognitive impairment. The resident had Risperdal orders written for PO administration even though nursing staff stated all meds were given via g-tube, and the CP acknowledged the discrepancy should have been caught and corrected.
A resident with dementia and severe cognitive impairment had an order for lorazepam 0.5 mg q4h PRN for anxiety without the required stop date. The Consultant Pharmacist identified the missing duration on repeated monthly pharmacy review reports, but the facility did not correct the order or otherwise resolve the irregularity noted in the pharmacy reports.
Failure to follow the Consultant Pharmacist’s recommendation for a PRN alprazolam order. A resident with anxiety and depression, and a BIMS score of 14/15, was observed upset and speaking loudly about a breakfast tray while staff intervened. The pharmacist noted that a duration must be specified for PRN psychoactive meds, but the resident’s alprazolam 0.5 mg PRN order had no stop date or documented rationale in the EMR, and the DON stated monthly pharmacist recommendations should have been completed within 1 to 2 weeks.
A CP failed to identify and document medication route discrepancies during the monthly DRR for a resident who was NPO and receiving TF. The resident had dysphagia, a gastrostomy, and a cerebral infarction, yet the MAR/POs included oral orders for Mylanta and Milk of Magnesia. The DON and UM confirmed the mismatch, and the CP report did not note the irregularity.
A resident with multiple chronic diagnoses, including pain-related and psychiatric conditions, had a monthly CP review that identified mismatches between PRN tramadol use and documented pain scores, along with an unclear PRN Tylenol-for-fever order. The MAR showed tramadol was administered multiple times for pain levels of 0, 2, and 6 despite the order being for severe pain, and the DON and an LPN acknowledged the medication was not given in accordance with the order.
A CP failed to identify an irregularity during the monthly DRR for a resident with CKD and anemia who was receiving Epogen. The resident had an order for Epogen injections with hematocrit monitoring, but no hold parameter was reflected, the CP did not recognize the boxed warning, and no recommendation was made to the prescriber regarding the medication review.
A consultant pharmacist failed to identify and report irregularities during the monthly MRR for a resident with multiple sclerosis, sepsis, acute kidney failure, and depression. The resident had duplicate cornstarch orders for overlapping skin areas and overlapping wound care orders for the same site, including routine and PRN directions for the same treatments, and there was no documented clarification of the conflicting PO.
The facility failed to timely address consultant pharmacist recommendations for two residents. One resident with dementia and ESRD had unresolved pharmacy concerns involving bisacodyl, MOM, and lisinopril BP documentation, while another resident had diltiazem administered without required BP hold-parameter documentation on the MAR. The DON and UM confirmed the recommendations were not completed within the facility’s expected timeframe and were not documented as addressed.
A resident with dementia, DM, CKD, HTN, and major depressive disorder had a CP drug regimen review recommending evaluation of the continued need for twice-daily fingersticks without current diabetic medication coverage. The physician marked the recommendation not accepted, but the chart had no PN or other documentation showing the clinical rationale for continuing the order, and the DON acknowledged the lack of rationale when interviewed.
A CP failed to report repeated irregularities during monthly MRR for a resident receiving Lovenox for clot prevention after fractures. The resident’s MAR showed numerous refusals of the anticoagulant over several months, while the CP’s monthly reports did not identify the refusals as an irregularity. The resident questioned the need for the injections, and facility staff and the CP acknowledged the refusals should have been recognized and reported.
Self-audit
Pick a level of detail and, optionally, what to focus on — then generate a survey-ready checklist distilled from the most recent citations.
Beta · AI-generated — for reference only, not professional advice. Verify against current CMS guidance before relying on it. Assisto accepts no responsibility for how this checklist is used.
Citations used to create this checklist
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release October 8, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.